16:50 , Oct 17, 2017 |  BC Innovations  |  Distillery Therapeutics

Ophthalmic disease

INDICATION: Glaucoma Mouse studies suggest activating Tie2 could help treat primary open-angle glaucoma (POAG). In a mouse model of POAG, intraocular injection of a Tie2-activating antibody decreased intraocular pressure compared with a control antibody. Next steps...